Smith & Nephew plc (NYSE:SNN) Shares Sold by Sivik Global Healthcare LLC

Sivik Global Healthcare LLC cut its holdings in Smith & Nephew plc (NYSE:SNN) by 10.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 125,000 shares of the medical equipment provider’s stock after selling 15,000 shares during the quarter. Smith & Nephew accounts for 1.6% of Sivik Global Healthcare LLC’s portfolio, making the stock its 27th biggest holding. Sivik Global Healthcare LLC’s holdings in Smith & Nephew were worth $3,073,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. R Squared Ltd purchased a new stake in Smith & Nephew during the 4th quarter worth about $41,000. Blue Trust Inc. raised its position in shares of Smith & Nephew by 26.0% in the 4th quarter. Blue Trust Inc. now owns 5,871 shares of the medical equipment provider’s stock worth $144,000 after buying an additional 1,213 shares during the period. Crossmark Global Holdings Inc. raised its holdings in shares of Smith & Nephew by 1.2% in the 4th quarter. Crossmark Global Holdings Inc. now owns 114,226 shares of the medical equipment provider’s stock worth $2,808,000 after purchasing an additional 1,367 shares during the period. Ridgewood Investments LLC lifted its position in Smith & Nephew by 6.1% during the fourth quarter. Ridgewood Investments LLC now owns 75,979 shares of the medical equipment provider’s stock valued at $1,868,000 after buying an additional 4,336 shares in the last quarter. Finally, GAMMA Investing LLC boosted its position in Smith & Nephew by 31.8% during the 4th quarter. GAMMA Investing LLC now owns 2,975 shares of the medical equipment provider’s stock worth $73,000 after purchasing an additional 718 shares during the period. Institutional investors and hedge funds own 25.64% of the company’s stock.

Smith & Nephew Stock Performance

Shares of SNN stock opened at $25.59 on Thursday. The company has a quick ratio of 1.11, a current ratio of 2.51 and a debt-to-equity ratio of 0.63. Smith & Nephew plc has a one year low of $23.65 and a one year high of $31.72. The company’s 50-day simple moving average is $25.03 and its 200-day simple moving average is $27.69.

Analyst Upgrades and Downgrades

Several analysts have issued reports on SNN shares. Berenberg Bank downgraded shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research report on Wednesday, November 6th. StockNews.com downgraded shares of Smith & Nephew from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, November 12th. Finally, Deutsche Bank Aktiengesellschaft cut shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research report on Friday, November 1st.

Smith & Nephew Company Profile

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.